PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-γ/CD36 Pathway

Curcumin has the potential to cure dyslipidemia and nonalcoholic fatty liver disease (NAFLD). However, its therapeutic effects are curbed by poor bioavailability. Our previous work has shown that modification of curcumin with polyethylene glycol (PEG) improves blood concentration and tissue distribu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomed Res Int
Autors principals: Liu, Yu, Cheng, Fei, Luo, Yuxuan, Zhan, Zhu, Hu, Peng, Ren, Hong, Tang, Huadong, Peng, Mingli
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5523402/
https://ncbi.nlm.nih.gov/pubmed/28770225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8234507
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars